Cargando…
The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects
The Herpevac Trial for Women revealed that three dose HSV-2 gD vaccine was 58% protective against culture-positive HSV-1 genital disease, but it was not protective against HSV-2 infection or disease. To determine whether vaccine-induced immune responses had selected for a particular gD sequence in s...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407825/ https://www.ncbi.nlm.nih.gov/pubmed/28448558 http://dx.doi.org/10.1371/journal.pone.0176687 |